Tottenham Hotspur's pursuit of Newcastle United midfielder Sandro Tonali has hit a snag, with Arsenal reportedly ready to enter the race for the Italian international. The north London rivals are now set to battle for a player whose transfer fee could exceed $100 million, adding a fresh chapter to their long-standing rivalry.
Spurs' rejected bid and Newcastle's leverage
Tottenham submitted an opening offer of approximately £80 million for Tonali in June 2026, but Newcastle swiftly rejected it. The Magpies are holding firm on a valuation between £85 million and £100 million, a range they can enforce given Tonali's contract runs until 2029 with no release clause. For Spurs, securing Tonali would signal a major statement of intent after a season that saw them flirt dangerously with relegation. The 26-year-old has proven his quality in the Premier League and for Italy, making him a prime target to rebuild the squad's midfield.
Arsenal's lurking presence
Arsenal's interest in Tonali is not entirely new. The player's representatives reportedly offered him to the Gunners on the January 2026 deadline day, though that deal fell through. Now, with Tottenham making the first move, Arsenal are considering a formal bid. According to insiders, Tonali himself would prefer a move to the Emirates Stadium over White Hart Lane if Mikel Arteta's side enters the race. Newcastle head coach Roberto De Zerbi is known to rate Tonali highly, and the club's control over the timeline—with three years left on his contract—gives them no reason to rush.
The north London transfer rivalry
Arsenal and Tottenham competing for the same player is a familiar scenario, but the stakes are unusually high this time. Arsenal can offer Champions League football, having consistently finished near the top of the Premier League in recent seasons. Tottenham, by contrast, are selling a vision of revival after a near-relegation campaign. At the upper end of Newcastle's asking price, the deal would cost close to £100 million, or over $120 million. Both clubs must now decide whether Tonali's impact justifies that outlay, especially with alternative targets available at lower prices.